Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Igm Biosciences Inc
(NQ:
IGMS
)
8.330
-0.380 (-4.36%)
Official Closing Price
Updated: 4:15 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Igm Biosciences Inc
< Previous
1
2
Next >
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
December 11, 2022
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference
December 01, 2022
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Present at Three Upcoming Investor Conferences
November 08, 2022
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update
November 03, 2022
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
November 02, 2022
From
IGM Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.